Vaccine study shows 55% effectiveness against hospitalizations

What's happened

A JAMA Network Open study finds the vaccine reduces COVID-19-related hospitalizations by about 55% and lowers visits to emergency departments by 50%. The paper has drawn attention because of past political interference in CDC publishing decisions. The study uses a test-negative design and is part of ongoing assessments of vaccine performance amid evolving viral strains.

What's behind the headline?

Context and method

• The study employs a test-negative design, a method used for decades to estimate vaccine effectiveness in real-time.
• Proponents say it accounts for care-seeking differences; critics worry about assumptions and potential biases.
• The debate mirrors broader questions about how best to monitor vaccines as immunity and variants evolve.

Why it matters

• If real-time estimates are reliable, health officials can adjust public health guidance more quickly.
• The controversy underscores ongoing tensions between public health researchers and political appointees over how data is presented.

How we got here

The study, slated for CDC publication, was cleared by the agency’s Office of Science but flagged by acting director Jay Bhattacharya, who asked authors to address concerns. It uses a test-negative design to compare vaccination status among those admitted for respiratory illness who test positive for COVID-19 vs those who do not.

Our analysis

Independent:worldview: The Independent reports the study shows ~55% effectiveness against hospitalizations and ~50% reduction in ED visits; notes past CDC publication friction. AP News: AP summarizes the same findings and details the forum at the CDC, highlighting the design and criticism by Martin Kulldorff. Both emphasize the ongoing debate about methodology and real-time vaccine effectiveness.

Go deeper

• What are the real-world implications if effectiveness is around 55% for hospitalizations?
• How might this influence future CDC publications or policy guidance?
• What does the test-negative design imply for interpreting vaccine performance?

More on these topics

• Emory University - Private university in Atlanta, Georgia

  Emory University is a private research university in Atlanta, Georgia. Gregory L. Fenves, formerly the president of UT Austin, became Emory University’s twenty-first president in August of 2020.

• Natalie Dean - Biostatistician

  Natalie E. Dean is an American biostatistician specializing in infectious disease epidemiology. Dean is currently an assistant professor of Biostatistics at the University of Florida.

• Robert F. Kennedy Jr. - American politician, environmental lawyer, anti-vaccine activist, and conspiracy theorist (born 1954)

  Robert Francis Kennedy Jr. (born January 17, 1954), also known by his initials RFK Jr., is an American politician, environmental lawyer, author, conspiracy theorist, and anti-vaccine activist serving as the 26th United States secretary of health and human

• United States Centers for Disease Control and Prevention - Public agency

  The Centers for Disease Control and Prevention is a national public health institute in the United States. It is a United States federal agency, under the Department of Health and Human Services, and is headquartered in Atlanta, Georgia.

• JAMA Network Open - Journal

  JAMA Network Open is a monthly open access medical journal published by the American Medical Association covering all aspects of the biomedical sciences. It was established in 2018 and the founding editor-in-chief is Fred Rivara.

• United States Department of Health and Human Services - Government department

  The United States Department of Health & Human Services, also known as the Health Department, is a cabinet-level executive branch department of the U.S. federal government with the goal of protecting the health of all Americans and providing essential

• Jay Bhattacharya - 18th director of the National Institutes of Health

  Jayanta Bhattacharya (born 1968) is an American health economist, trained as a physician, who has served as the 18th director of the National Institutes of Health since 2025. Bhattacharya additionally served as the acting director of the Centers for Disea

• United States - Country in North America

  The United States of America, commonly known as the United States or America, is a country mostly located in central North America, between Canada and Mexico.

• Martin Kulldorff - Biostatistician

  Martin Kulldorff, is a professor of medicine at Harvard Medical School and a biostatistician and epidemiologist at the Brigham and Women's Hospital.

• Great Barrington Declaration - Libertarian proposal to end most COVID-19 restrictions for those at low risk; "Focused Protection" is advocated

  The Great Barrington Declaration is a proposal written and signed at the American Institute for Economic Research in Great Barrington, Massachusetts on 4 October 2020.